reported that the self-renewal and tumorigenesis of glioma stem cells (GSCs) were regulated by m6A RNA methylation, and an m6A mRNA demethylase FTO inhibitor could suppress the progression of GSC-initiated tumor (14). This evidence concerns the gene FTO and neoplasm.